Biotest AG: Biotest AG: Annual general meeting approves increase of dividend
Biotest AG / Key word(s): AGM/EGM / Biotest AG: Annual general meeting approves increase of dividend - Distribution of EUR 0.50 per ordinary share and EUR 0.56 per preference share Dreieich / Frankfurt a. M., 8 May 2013. At the annual general meeting (AGM) held on 8 May 2013 in Frankfurt am Main shareholders of Biotest AG approved payment of an increased dividend. With 82,4 percent of the ordinary share capital represented at the meeting, a payment of EUR 0.50 per ordinary share and EUR 0.56 per preference share met with wide endorsement. This equates to a dividend increase of 13.6% relative to last year for ordinary shares and 12.0% for preference shares. The overall distribution will amount to EUR 6.2 million. The annual general meeting attended by around 180 shareholders and guests also formally discharged the members of the Management and Supervisory Boards for financial year 2012 and endorsed all of the other agenda items by a large majority. The full text of the address given by Professor Gregor Schulz at the AGM is available at: http://www.biotest.de/ww/de/pub/investor_relations/ hauptversammlung.cfm. Disclaimer This document contains forward-looking statements on overall economic development as well as on the business, earnings, financial and assets position of Biotest AG and its subsidiaries. These statements are based on current plans, estimates, forecasts and expectations of the company and are thus subject to risks and elements of uncertainty that could result in significant deviation of actual developments from expected developments. The forward-looking statements are only valid at the time of publication. Biotest does not intend to update the forward-looking statements and assumes no obligation to do so. About Biotest Securities' ID No., ISIN ordinary shares: 522720, DE0005227201 End of Corporate News 08.05.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.medientreff.de and www.dgap.de |
Language: | English | |
Company: | Biotest AG | |
Landsteinerstraße 5 | ||
63303 Dreieich | ||
Germany | ||
Phone: | 0 61 03 - 8 01-0 | |
Fax: | 0 61 03 - 8 01-150 | |
E-mail: | investor_relations@biotest.de | |
Internet: | http://www.biotest.de | |
ISIN: | DE0005227235, DE0005227201 | |
WKN: | 522723, 522720 | |
Indices: | SDAX | |
Listed: | Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, Stuttgart | |
End of News | DGAP News-Service |
210451 08.05.2013 |